Loading

Quibron-t

P. Kafa. University of Newport.

It is also essential that the sample size be large enough to build a concrete picture of the distribution of gene variants in individuals free of specific diagnoses 400 mg quibron-t otc. Example Pilot Study 2: Metabolomic profiles in Type 2 Diabetes Recent metabolomic profiling of blood samples from individuals who subsequently developed type 2 diabetes showed marked differences in the characteristics of branched-chain amino acids sampled from blood draws (Wang et al cheap quibron-t 400mg without prescription. These early analyses suggest the potential of metabolomic analyses to help identify those individuals at most risk of developing diabetes discount quibron-t 400 mg with visa, and in particular order quibron-t 400 mg line, may help to elucidate the physiological steps involved in the transition between insulin resistant pre-diabetes and full-blown diabetes. We therefore envision a pilot project focused on understanding this transition using metabolomic profiles in blood. This work would begin with targeted quantitative metabolomic studies transitioning towards more comprehensive metabolomic profiles over time. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease 56 gained from Pilot 1 and research from other layers of the Information Commons (such as the microbiome and exposome) could contribute substantially to strategies to delay or prevent the development of type 2 diabetes. Anticipated outcomes of the pilot studies The pilot studies are intended to lead to new connections between genetic or metabolomic variation and disease sub-classifications, often with implications for disease management and prevention. More importantly, they will provide the lessons necessary to facilitate a more rapid transition in the way molecular data are used. For example, pilot projects of sufficient scope and scale could lead to the development of new discovery models, including those in which patient groups self-organize in recognition of shared clinical features and then pursue efforts to generate relevant molecular data. Such an initiative also would permit many logistical, ethical, and bioinformatic challenges to be addressed in ways that would benefit future efforts and lead toward the sustainable implementation of point-of-care discovery efforts. A research model based on open data sharing requires changes to data access, consent and sharing policies Research to develop a Knowledge Network of Disease will need to resolve complex ethical and policy challenges including consent, confidentiality, return of individual results to patients, and oversight (Cambon-Thomsen et al. The Committee’s vision of a Knowledge Network of Disease and its associated benefits for future patients will become a reality only if the public supports a new balance between research access to materials and clinical data and respect for the values and preferences of donors. Ultimately, there should be no dichotomy between “patient data or materials” and “those who benefit from this research. How might these ethical and policy challenges be resolved so that the pilot studies described previously might be carried out? The Committee recommends that an appropriate federal agency initiate a process to assess the privacy issues associated with the research required to create the Knowledge Network and Information Commons. Because these issues have been studied extensively, this process need not start from scratch. However, in practical terms, investigators who wish to participate in the pilot studies discussed above—and the Institutional Review Boards who must approve their human-subjects protocols— will need specific guidance on the range of informed-consent processes appropriate for these projects. Subject to the constraints of current law and prevailing ethical standards, the Committee encourages as much flexibility as possible in the guidance provided. As much as possible, on-the-ground experience in pilot projects carried out in diverse health-care settings, rather than top-down dictates, should govern the emergence of best practices in this sensitive area, whose handling will have a make- or-break influence on the entire information-commons/knowledge-network/new-taxonomy initiative. Inclusion of health-care providers and other stakeholders outside the academic community will be essential. Intensive dialog about the benefits of an Information Commons containing individual-centric data about health and disease. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease 57 patient representatives, and disease advocacy groups. Reaching out to communities that have been suspicious of research because of historical abuses would strengthen trust. At the workshop the Committee convened, we heard patient advocates and public representatives argue forcefully that more transparency regarding research and more collaboration among researchers, research institutions, and the public would facilitate research. For example, when constructively engaged, advocacy groups have advanced biomedical research by helping to design studies that are attractive to patients, publicized the projects, helped to recruit participants, and raised money to help pay for the research. Exploration of approaches to informed consent that would allow patients to give broad consent for future studies whose details remain unspecified. On the other hand, some patients will object generally to the research use of “leftover” specimens originally collected for clinical purposes or, more narrowly, object to their use in certain types of research. Current approaches to informed consent for research rely on long, complex consent forms that may deter participation while doing little to help participants understand the nature of the research. Public participation in biobanks and research projects would build trust (Levy et al. Although a waiver of authorization to use identifiable health information may be granted under certain circumstances, many health care organizations are reluctant to participate. Thirdly, requirements for “accounting” to patients for research uses of data are burdensome and discourage data sharing. These regulations are strong deterrents to the kinds of pilot projects envisaged in this report. A biobank might serve as a trusted intermediary for the pilot projects described above, giving researchers only data and materials without overt identifiers but retaining a key to coded samples so they could update clinical information or re-contact patients or donors when appropriate. The Committee envisages that best practices and ultimately consensus standards will emerge from the different models of consent and return of clinically significant results to participants. The research needed to build the Information Commons, which will require projects involving vast amounts of data from large numbers of patients, will proceed more efficiently if such collaborations can be developed both between academia and industry and among for-profit companies that have historically been competitors (Altshuler et al. These collaborations could include developing common standards and database formats and building infrastructure to facilitate data sharing. Consortia might be organized to share upstream research findings widely that have no immediate market potential but are critical to downstream product development. Examples of such upstream research include the identification and validation of biomarkers and predictors of adverse drug reactions. To build a flourishing culture of pre-competitive collaboration, drug companies will need to overcome their reluctance to share all data from completed clinical trials, not just the selected data relevant to regulatory proceedings. Finally, and most significantly, guidelines for intellectual property need to be clarified and concerns about loss of intellectual-property rights addressed. Precompetitive collaborations will only emerge if individuals and organizations have incentives to join them (Vargas et al. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease 59 with its attendant benefits in improved health outcomes and reduced health-care costs, can become a widespread reality. Similar principles apply whether the collaborations involve commercial entities or are confined to academia. To encourage the collection of materials and data, organizations and researchers who collect them should have first access to their use for research, while still ensuring their timely availability to others. The Committee does not envision the desirability or need, in the context of the research required to populate the Information Commons with data and derive a Knowledge Network from it, for the instant-data-release model adopted during the Human Genome Project. However, it does believe that timely, unrestricted access to data sets by researchers with no connections to the investigators who created them will be essential. The cost of populating the Information Commons with data precludes extensive redundancy in publicly financed research projects. At the same time, the size and complexity of these data sets—as well as the need for diverse, competitive inputs to their analysis—precludes giving any one group prolonged control over them. They must be regarded as public resources available for widespread and diverse research into ways to improve health care and to increase the efficiency of health care delivery.

Measurements were performed separately for each radionuclide and independently for preparation and administration order 400mg quibron-t otc. For each worker buy quibron-t 400 mg on line, a set of 4–5 measurements were taken cheap quibron-t 400mg amex, except for therapy discount quibron-t 400 mg with amex, where this was not always achievable. The least exposed positions were found to be the wrists, followed by the bases of the fingers. A clear trend was observed for the non-dominant hand to be more exposed than the dominant hand, in particular for radionuclide preparation. For therapy, spatial dose inhomogeneity is usually much more pronounced, but generally also the same positions as for diagnostics were the most exposed. In most cases, the index tip of the non-dominant hand is the most exposed specific position. It is shown that preparation of radiopharmaceuticals involves higher finger doses per unit activity than administration because the procedures take longer and there are more steps requiring manipulations of the vials and/or syringes with higher activities, some of them without a shield. Therapy procedures involve generally higher mean 18 normalized skin dose to the hands than diagnostics. Within diagnostics, F 99m involves higher skin doses per unit activity than Tc because of the different dose rates at contact. The Monte Carlo simulation sensitivity study revealed that short source displacements (of up to a few centimetres), orientation and volume changes (of up to 3 mL) can increase the maximum dose by a factor of three to five depending on the source. Shielding was found to be the most important parameter affecting skin dose levels, both for diagnostics and especially for therapy. Even though the use of shields slows down the whole procedure, increases the difficulty of visualizing the required volume and offers less comfort, especially for heavy and thick shields, it provides a protection which mostly cannot be replaced by increasing working speed. Often, staff are not aware that near the bottom of a shielded syringe the dose rate is very high. Using tweezers is a very effective means of dose reduction when vials or syringes have to be held without a shield and also during connecting and separating the syringe to or from needles or butterflies. The ratios between the highest dose and the dose at the most common monitoring positions were calculated and are summarized in Table 2. It is shown that even with the exclusion of outliers, the distribution of ratios is very wide. For the recommended monitoring position (base of the index finger), a factor of six must be applied to estimate the maximum dose. Finally, it should be noted that there is broad agreement that, in nuclear medicine, the ring dosimeter should be preferred to the wrist dosimeter, which underestimates the maximum dose by a factor of 20. If, for practical reasons, these measurements are not possible, the base of the index finger of the non-dominant hand with the sensitive part of the dosimeter placed towards the inside of the hand is the recommended position for routine extremity monitoring in nuclear medicine. This is a precondition, but not a guarantee for low exposure, since not all parts (e. In recent years, there has been rapid technological development of hardware and software, new procedures, new treatment protocols and novel application of radionuclides. The major challenges of radiation protection for new techniques and new procedures in radiotherapy are their complexity and the high radioactivity of the applied sealed or unsealed sources. Radioactive sources — unsealed or sealed — are characterized by their type of radiation, the particle energy, the chemical composition, and their format and size. In addition, such sources cannot be switched off easily as can be done with X ray machines and accelerators. Thus, there is a high potential for the occurrence of accidents with serious consequences with such applications. In recent years, there have been reports of accidents in which there were unnecessary exposures to a large number of patients. Improving patient dosimetry and avoiding unnecessary exposures, particularly in unusual and novel applications, are important goals in medical radiation protection, in particular as international recommendations and basic safety standards in radiation protection do not suggest and implement any exposure limits for medical exposure. Appropriate control of the correct functioning of devices (hardware and software) as well as of the dose delivered to the patient is necessary. Beyond that, radionuclide therapy demands radiation protection measures for medical staff, comforters, caregivers and members of the public. Staff members can be exposed during preparation and application of high activity unsealed sources, e. Partial high skin doses exceeding the limits for occupational exposure are measured in connection with these procedures. To reduce the doses, it is essential to increase staff awareness as part of an appropriate radiation protection culture. Improved occupational radiation protection of medical staff has to be a fundamental element in the establishment of new techniques and new procedures, connected with appropriate training in both the technical skills and radiation protection. Issues, such as patient release, that are connected with exposure of family members, caregivers, hotel workers and those travelling with public transport, have to be taken into account, considering the legal limits for public exposure. In addition, the impact on the environment/cost to the population has to be assessed in this context. Owing to the high activity of these sources, there was an increased risk for operators and patients to be exposed unnecessarily. Since the late 1960s, the risk of unnecessary radiation exposure could be evidently reduced by using newly developed remote afterloading systems and also other radioactive sources. Nowadays, brachytherapy is considered a safe and effective treatment for many types of cancer supplemented by 3-D imaging modalities and computerized treatment planning systems. Nevertheless, the management of highly radioactive sources and the associated equipment still requires attention. The team play between operator and manufacturer is essential, considering the accidents that have happened with brachytherapy equipment recently. For instance, 28 incidents occurred in Germany in the past ten years, with causes such as construction errors, insufficient training, malfunctions (sources stuck outside of the shielding) and systematic error in calculation of the dose (overdose). It is obvious that manufacturers also have a non-negligible responsibility for radiation safety in the medical application. This treatment method is an excellent example of an expanding technology and the development of new types of machine. For instance, compact mobile X ray sources are used inside the ‘open’ body of a patient: that means that the source of radiation is located close to the tumour. It is a challenge for radiation protection because it is difficult to verify exactly the dose given to the patient. The local medical physicist discovered, with phantom measurements, a discrepancy between the calibration files of the two applicators which could cause a treatment dose 20% different from that intended. To ensure error-free function, effective internal quality control procedures are necessary. Highly sophisticated software, which is increasingly inseparably connected with newer technologies and techniques, has to undergo a stringent validation procedure. Radionuclide therapies with unsealed sources hold the risk for incorporation by medical staff during the preparation and application of the radiopharmaceuticals, as well as for external exposure by contamination. Furthermore, external and internal contaminations of members of the public after the release of therapy patients or the discharge of radionuclides into the environment have to be taken into account in safety assessments.

purchase quibron-t 400mg online

Greater elevations should be thoroughly investigated and may require nephrological consultation quality 400mg quibron-t. High sodium intake reduces effectiveness of antihypertensive therapies and is determined best by a 24-h urine sodium collection generic quibron-t 400 mg overnight delivery. The prevalence of proteinuria is 4–8% worldwide and 10–20% in hypertensive cheap 400 mg quibron-t mastercard, obese buy quibron-t 400mg cheap, and/or diabetic populations. The presence of even small amounts of albuminuria (>10 mg/g) is associated with adverse cardiovascular outcomes. Types of Proteinuria Traditionally, normal urinary protein excretion is considered to be <150 mg/24-h; total urinary proteins measured are comprised of immunoglobulins, assorted globulins, and Tamm-Horsfall mucoprotein. Persistently elevated total urinary protein signifies: a) defect(s) in the glomerular basement membrane b) impaired tubular protein reabsorption, eg, tubulointerstitial nephritis c) increased filtration of low molecular weight protein(s), ie, “overflow proteinuria” as may occur with light chains. Persistent proteinuria is defined as two or more positive quantitative tests of protein excretion, separated by at least 2 weeks. Common, benign sources of albuminuria/proteinuria include orthostatic proteinuria, intense activity/exercise, and fever. The urinalysis dipstick may not register proteinuria when the urine is highly dilute, (ie, specific gravity 1. Notably, a new classification system that eschews the terms micro- and macroalbuminuria may be established in the near future. The urine dipstick favors albumin detection and is relatively insensitive for tubular proteinuria, eg, immunoglobulin light chains. If tubular proteinuria is suspected, specific qualitative and quantitative examinations may be required, eg, serum free light chain analysis (Freelite™) and serum and urine immunofixation. For screening purposes, a 24-h urine is unnecessary, but if a serum monoclonal protein is detected, a 24-h urine collection for immunofixation is indicated. Consultation with a clinical laboratory expert is advised to optimize diagnostic yield in such cases. Patients with stable, persistent proteinuria of <1 g/24-h have a very small risk of progression to kidney failure compared to individuals with greater proteinuria. Inflammation upregulates hepcidin, a liver-synthesized protein that reduces gut iron absorption and impedes iron release from the reticuloendothelial system to the developing erythron. To correct iron deficiency, oral iron should always be tried initially, and multiple iron salt preparations are available. Darbepoetin alfa (Aranesp )® : 40–300 mcg, subcutaneously, q2–4 wk or q1 mo; begin therapy at Hb <10 g/dL at starting dose, 0. Calcification occurs most frequently in coronary arteries, aorta, and cardiac valvular leaflets. However, therapeutic interventions have increased the prevalence of adynamic bone disease. Currently, P binders remain a mainstay of therapy in patients with elevated levels. Vitamin D includes vitamins D2 and D3 and three active D sterols, calcitriol, and two synthetic vitamin D2 compounds. Paricalcitol, a calcitriol analog, is active upon administration and does not require in vivo activation. Doxercalciferol and paricalcitol exert vitamin D-like actions and are less prone to induce hypercalcemia than calcitriol. During Ca-based P-binder therapy, the total daily elemental Ca intake (dietary + prescribed) should not exceed 2000 mg daily. Sevelamer hydrochloride, a non-metal anion exchange resin, and lanthanum carbonate are non-Ca-based P-binders. These agents may be used as initial P-binder therapy, if arterial/cardiac vascular calcification is present or, if the corrected Ca is >10. Trend analysis of each parameter is preferred over treatment(s) directed at absolute parameter levels. Only rarely should a single abnormal value of Ca or P warrant discontinuation of active vitamin D sterols. Lipid evaluation should be conducted at initial evaluation, 2–3 months after treatment changes, and at least, annually afterward. Hypoalbuminemia and related nutritional disorders, including vitamin and mineral deficiencies are common. Preventing malnutrition through periodic visits to a trained renal nutritionist for nutrition surveillance is recommended and may avert complications. Protein Intake High biological value protein intake should be maintained, while sodium, potassium, and phosphorus intake are restricted. A controlled protein diet slows the decline of kidney function more than one with more liberal protein intake. Monitoring A 24-h urine collection for sodium (goal <100 mEq Na per 24-h), urea nitrogen and creatinine is highly informative regarding the level of compliance with a dietary prescription. To preserve lean body mass, a supervised exercise regimen should be considered in conjunction with dietary recommendations. Lastly, booster vaccinations with tetanus toxoid, diphtheria, and acellular pertussis vaccines (Tdap) may be administered alone or co-administered with any of the vaccines listed below. Revaccination with a single dose may be considered 5 years after the last dose in persons 65 y. Tetanus, diphtheria (Td); Tetanus, diphtheria and pertussis (Tdap) Td Dose 1 of initial series: 0. Therefore, conservative management, when chosen, focuses the shift from simply attempting to prolong life to providing quality of life and alleviation of symptoms. Physical conditions such as vision and manual dexterity, motivational level to actively participate in care, and family/social circumstances all play roles in the decision-making process. Peritoneal dialysis as a modality option was discussed with 61% of patients before initiation of dialysis. Peritonitis can be treated with intra-peritoneal or iv antibiotics and may require catheter exchange. Notably, the failure of access function limits the delivered dose of dialysis, a major survival determinant. Vascular Access Planning and Construction Key issues include timely nephrology referral; vein preservation; vascular access creation planning; timely referral to a surgeon specialized in access construction; post-construction follow- up; and appropriate intervention(s). The patient should be evaluated by venous mapping, preferably by ultrasound duplex scanning of the non-dominant arm (non-hand writing); if unsuitable, the dominant arm may be used for access creation. Therefore, vein preservation during hospitalizations and outpatient care must occur. Educational programs reinforcing the above should be provided to patients, their families and healthcare providers. Alternative therapies should be explored in each clinical circumstance and the risk-to-benefit ratio of any agent must be determined by the prescribing individual. Pharmacy consultation is advised to optimize drug dosing, particularly in cases of acute kidney injury. The most common sign of acute tubulointerstitial nephritis is hematuria, although classically, leukocyte casts are associated with this disorder. Microscopic evaluation of the urine should be used to confirm this often “missed” disorder.

generic quibron-t 400mg on-line

It should be built into the daily timetable as a scheduled activity and should be compulsory buy quibron-t 400mg lowest price. The importance of exercise has to be balanced against the energy expended undertaking it buy generic quibron-t 400mg on-line. If you are relying on a very simple food storage programme with only the core staples then you will have problems quickly cheap quibron-t 400 mg free shipping. If you have stored a broad range of items cheap quibron-t 400mg with amex, and tinned, and bottled foods in addition to dry staples then it will be less of a problem. If you are in the former group as an absolute minimum you should ensure that you have an adequate supply of multivitamin supplements If you are planning long-term shelter living you should give serious thought to developing a system for gardening within your shelter. Hydroponics is the obvious solution and can be relatively easily grown in a shelter type environment, however, it still requires large amounts of light, water, and nutrients to grow. The nutrient value depends on the type of bean used, how long it is allowed to grow, and the - 88 - Survival and Austere Medicine: An Introduction amount of light it is exposed to. The more light and the longer the growth period the more vitamin A and C will be present with peak levels present at 8 days. In uncooked legumes (beans, peas, lentils) an enzyme which blocks the absorption of protein, is present. The Prudent Pantry, A T Hagan, 1999 – no out of print) - 89 - Survival and Austere Medicine: An Introduction Chapter 11 Long-term austere medicine Introduction Most of what is discussed in this book is related to a short to medium term disasters with serious disruption of medical services, but with a view to eventual recovery to a high technological level in the short to median term, certainly within a generation. The above paints a possible scenario for what may happen in a major long term disaster – a complete permanent collapse of society and, with that medical services; no hospitals, no new supplies or medications, no medical schools, and no prospect of a significant degree of technological recovery. Depending on your level of preparedness (or paranoia) possible scenarios include comet strike, massive climate change, global pandemic, or worldwide nuclear war any of which would result in complete disruption of infrastructure, and knowledge, and an inability to recover to today’s modern level. While all the principles discussed in other sections apply to the early stages of these sorts of disasters what happens when things run out for good, or the doctor/medic in your group is getting old, or dies raises a whole series of other issues. In this section we cover some of the main issues about long-term medical care in a primitive / austere environment. It is not a “how-to” chapter but more a discussion of likely scenarios and thoughts about what is possible and what is not. Despite the pessimistic picture painted in the scenario above with planning and thought it is possible to maintain a surprisingly high level of medical care. We are not talking heart transplants and high-level intensive care, but we are talking quality medical care which can manage even if it cannot cure common medical problems. While at first thought it may appear that the loss of modern technology and medication will place medical care back to the dark ages it is important not to forget that the knowledge underpinning modern medicine is still there. While there may be no antibiotics for your dirty wound you still have an understanding of what causes infection, basic hygiene measures, and good basic wound care so while you may not have antibiotics to prevent or treat infection you will still know how to minimise the chance of infection, and optimise healing, and hopefully a knowledge of other substances with antibacterial properties. For this reason it is extremely important that you have a comprehensive medical library to begin with and that there is a priority to preserve the knowledge the books contain. Having several people with detailed medical knowledge initially is ideal but this for many may not be possible. It is important that there is a degree of cross training within the group at least at a basic level. When it is apparent that a - 90 - Survival and Austere Medicine: An Introduction disaster is likely to be prolonged it is vital that you begin to train someone to the same level as yourself; the best way is probably using an apprenticeship model over several years. This was the way the majority of western doctors (Middle Eastern cultures th have had medical schools for the last 1500 years) were taught until the 17 century when the medical schools took over, and apprenticeships were still common up until early last century although they were considered inferior. Unfortunately learning medicine simply from a book is inadequate and having supervised experience in addition to books is the only real way to learn. For this reason if you are considering a long-term collapse ensure that you also have the resources to teach the basics of biological sciences first before moving onto medicine proper. It would be difficult to teach someone the complexities of medicine without a good understanding of the basics. In addition to modern medical knowledge, if you are planning for a multi-generational catastrophe then you need to study medical history. The practice of medicine in the th th 18 and 19 Century provides, in our opinion, what we may realistically expect in terms of a technological level in medicine with our modern knowledge superimposed over the top. Look at how things were done, and with what instruments, what medications where used, and how; what were the medical problems encountered? Much from that time is simply wrong and reflects the ignorance of physiology and pathology of the times but there is much to learn, and when approached with modern knowledge it is easy to identify what is useful information and what is not. An interesting way to appreciate the medical problems of the time is by looking at the causes of death during that period; this gives some insight into likely serious medical problems in this sort of scenario now. Below are some of the commonest causes of th death in early 19 Century in Australia. In addition to showing causes of death they also show some of the limited medical understanding of the time: • Trauma (including drowning and burns) – deaths from drowning and burns appear to have occurred with frightening frequency. There were also a large number of trauma deaths – both as a consequence of (mostly) farming accidents and violence. While covering a number of different diagnosis for the most part it referred to heart failure and commonly followed episodes of severe chest pain although at the time this wasn’t recognised for what it was – a myocardial infarction • Abdominal distemper – this was a syndrome characterised by severe abdominal pain, abdominal rigidity, fevers, and death. A significant number of cases were probably appendicitis although it is likely that pancreatitis, liver disease (from alcohol abuse), and gallbladder infections accounted for a number of cases. Again, more recently the term referred to typhoid fever, prior to this it referred to any dysentery. They divided them into one of three groups: • those conditions that can be treated • those that can be contended with • those that cannot be treated It is simple but surprisingly useful because in an austere situation it gives a framework to classify what you can do for your patients; those you can treat and cure, those that you can palliate or make comfortable (until they die or get better), and those that you can do nothing for or where your intervention is likely to make things worse. You need to convey a realistic expectation to your patients of what you will be able to achieve and this provides a simple framework. Lifestyle/Public health Lifestyle: Prior to any disaster it is worth considering what you can do to improve your own and your group’s health. Prevention of diseases such as heart disease, strokes, and diabetes is much better than attempting to treat them in an austere survival situation. You should ensure that all members of your group have their vaccinations up to date especially tetanus, measles, diphtheria, and polio. Preventive medicine: A large proportion of the disease burden in the past is related to poor public health and preventive medicine. For the most part it was related to ignorance of the role of bacteria in causing disease. Key elements of preventive medicine and infection control include: • Clean drinking water – uncontaminated by sewage and waste water • Hand washing – soap production is a priority. Incineration is probably the best option, followed by deep burial – away from water sources. Adequate rubbish disposal and trapping are probably the best methods for rodent control. Depending on climate mosquitoes may be a problem; stagnant water and rotting soft wood are foci for the mosquito larvae. Although many illnesses are infectious before symptoms become apparent it is important that any person who becomes unwell, particularly with fever or diarrhoea, is isolated immediately in an attempt to minimise further infections.

Support PUT

General Donations

Top Sponsors

Social

Like Us